| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.795 | 31.433 | 28.793 | 24.542 | 26.810 | 21.461 | 20.632 | 18.639 | 17.761 | 18.040 |
| Total Income - EUR | 34.903 | 31.434 | 28.794 | 24.542 | 26.810 | 21.505 | 20.632 | 18.639 | 17.761 | 18.040 |
| Total Expenses - EUR | 24.456 | 11.483 | 12.648 | 11.855 | 11.059 | 10.895 | 9.094 | 8.779 | 11.792 | 11.900 |
| Gross Profit/Loss - EUR | 10.447 | 19.951 | 16.145 | 12.687 | 15.750 | 10.610 | 11.538 | 9.860 | 5.969 | 6.141 |
| Net Profit/Loss - EUR | 9.521 | 19.008 | 15.281 | 11.951 | 14.946 | 9.966 | 10.919 | 9.301 | 5.014 | 5.158 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Abimedsan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.851 | 19.436 | 16.684 | 13.818 | 11.247 | 9.716 | 7.602 | 7.104 | 5.102 | 3.212 |
| Current Assets | 15.294 | 10.837 | 6.725 | 20.600 | 6.654 | 2.518 | 4.668 | 4.294 | 1.943 | 8.370 |
| Inventories | 70 | 0 | 0 | 0 | 302 | 731 | 0 | 0 | 0 | 0 |
| Receivables | 423 | 7.976 | 4.067 | 1.299 | 1.100 | 995 | 0 | 0 | 0 | 5.861 |
| Cash | 14.801 | 2.862 | 2.658 | 19.301 | 5.253 | 792 | 4.668 | 4.294 | 1.943 | 2.509 |
| Shareholders Funds | 37.897 | 19.943 | 16.201 | 12.853 | 15.831 | 10.945 | 11.890 | 10.274 | 5.985 | 6.123 |
| Social Capital | 900 | 891 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | 248 | 10.330 | 7.208 | 21.565 | 2.070 | 1.289 | 381 | 1.124 | 1.061 | 5.459 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Abimedsan Srl